Jeffrey S Miller MD

PubMed

• 15 citations
  Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
  Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada
  Prostate Cancer and Prostatic Diseases. 2025-03-01
• 3 citations
  A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer.
  Shee Kwan Phung, Nicholas A Zorko, Yvette Soignier, Rhett L Waller, Madison Shackelford
  Cancer Immunology Research. 2025-02-03
• 5 citations
  Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.
  John R Lozada, Andrew Elliott, Mark G Evans, James Wacker, Kathleen M Storey
  Cancer Research Communications. 2025-02-01

Journal Articles

• Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source,  
  Erhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel, Haematologica
• Phase I Trial of ALT-803, a Novel Recombinant Interleukin-15 Complex, in Patients  
  Jeffrey S Miller, Shernan G Holtan, Sylvia M Lee, Chihiro Morishima, Ann, Clinical Cancer Research

Abstracts/Posters

• Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural
  Jeffrey S. Miller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• NK Cells Lacking CD38 Are Resistant to Oxidative Stress-Induced Death
  Jeffrey S. Miller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• PD-1 Is Expressed at Low Levels on All Peripheral Blood Natural Killer Cells
  Jeffrey S. Miller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• iPSC-Derived NK Cells Synergize with T Cells and Anti-PD-1 Antibody to Mediate 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019